---
title: "Tegafur - Stomach Neoplasms"
sidebar: mydoc_sidebar
permalink: db09256-mesh-d013274-1.html
toc: false 
---


Path ID: `DB09256_MESH_D013274_1`
{% include image.html url="images/db09256-mesh-d013274-1.png" file="db09256-mesh-d013274-1.png" alt="db09256-mesh-d013274-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D005641">MESH:D005641 </a> | Tegafur | Drug |
| <a href="https://identifiers.org/MESH:D005472">MESH:D005472 </a> | Fluorouracil | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D005468">MESH:D005468 </a> | Fluorodeoxyuridylate | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:C025635">MESH:C025635 </a> | 5-fluorouridine 5'-triphosphate | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P04818">UniProt:P04818 </a> | Thymidylate synthase | Protein |
| <a href="https://identifiers.org/GO:0071897">GO:0071897 </a> | DNA biosynthetic process | BiologicalProcess |
| <a href="https://identifiers.org/GO:0032774">GO:0032774 </a> | RNA biosynthetic process | BiologicalProcess |
| <a href="https://identifiers.org/CL:0001063">CL:0001063 </a> | neoplastic cell | Cell |
| <a href="https://identifiers.org/MESH:D013274">MESH:D013274 </a> | Stomach Neoplasms | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tegafur | HAS METABOLITE | Fluorouracil |
| Fluorouracil | HAS ACTIVE INGREDIENT | Fluorodeoxyuridylate |
| Fluorouracil | HAS ACTIVE INGREDIENT | 5-Fluorouridine 5'-Triphosphate |
| Fluorodeoxyuridylate | DECREASES ACTIVITY OF | Thymidylate Synthase |
| Thymidylate Synthase | POSITIVELY REGULATES | Dna Biosynthetic Process |
| Dna Biosynthetic Process | OCCURS IN | Neoplastic Cell |
| 5-Fluorouridine 5'-Triphosphate | DISRUPTS | Rna Biosynthetic Process |
| Rna Biosynthetic Process | OCCURS IN | Neoplastic Cell |
| Neoplastic Cell | CONTRIBUTES TO | Stomach Neoplasms |
|---------|-----------|---------|

Comment: Tegafur has the active antineoplastic metabolite, 5-fluorouracil (5-FU). The 5-FU is then converted into 5-fluoro-deoxyuridine-monophosphate and 5-fluorouridine-triphosphate in the cell.

Reference: 
  - [https://go.drugbank.com/drugs/DB09256#mechanism-of-action](https://go.drugbank.com/drugs/DB09256#mechanism-of-action)
  - [https://drugs.ncats.io/substances?q=%22TEGAFUR%22](https://drugs.ncats.io/substances?q=%22TEGAFUR%22)
  - [https://www.uniprot.org/uniprot/P04818#function](https://www.uniprot.org/uniprot/P04818#function)
  - [https://en.wikipedia.org/wiki/Stomach_cancer](https://en.wikipedia.org/wiki/Stomach_cancer)
